Role of Iberin as an anti-apoptotic agent on renal ischemia-reperfusion injury in rats.
| Autor: | Yahiya YI; Deptartment of Pharmacology, Faculty of Pharmacy, University of Alkafeel, Najaf, Iraq., Hadi NR; Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Kufa, Iraq., Abu Raghif A; Deptartment of Pharmacology, College of Medicine, Al Nahrain University, Baghdad, Iraq., Qassam H; Deptartment of Pharmacology, Faculty of Pharmacy, University of Alkafeel, Najaf, Iraq., Al Habooby NGS; Medical College, University of Kufa, Kufa, Iraq. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of medicine and life [J Med Life] 2023 Jun; Vol. 16 (6), pp. 915-919. |
| DOI: | 10.25122/jml-2022-0281 |
| Abstrakt: | Ischemia-reperfusion injury (IRI) is a major contributor to acute and chronic kidney failure, heart failure, and ischemic stroke. This study aimed to investigate the therapeutic potential of Iberin, known for its anti-inflammatory, antioxidant, and antiapoptotic properties, in a rat model of renal IRI. Twenty-four adult male rats were randomly divided into four groups: Group I (Sham group) underwent laparotomy without IRI induction; Group II (Control group) underwent laparotomy followed by renal artery clamping for 30 minutes to induce ischemia, followed by 2 hours of reperfusion; Group III (Iberin treatment group) received a pre-injection of Iberin (15 mg/kg) and underwent 30 minutes of ischemia followed by 2 hours of reperfusion; and Group IV (Vehicle-treated group) received the vehicle (ethanol) 1 hour prior to ischemia and reperfusion induction. Iberin was diluted with ethanol. Biomarkers associated with inflammation, oxidative stress, and apoptosis were measured using enzyme-linked immunosorbent assay. Iberin treatment significantly reduced levels of inflammatory cytokines interleukin-1β (IL-1β) and IL-6, Bcl-2-associated X protein (BAX), tumor necrosis factor α (TNF-α), nuclear factor kappa p56, high mobility group B1, and neutrophil gelatinase-associated lipocalin. Moreover, Iberin increased levels of heat shock protein and Bcl2 compared to the control and vehicle groups. Iberin treatment prolonged the ischemic tolerance of renal tissue, potentially preventing or delaying irreversible injuries. These findings highlight the potential of Iberin as a promising candidate for mitigating renal injury caused by ischemia-reperfusion, due to its ability to modulate inflammatory markers. Competing Interests: The authors declare no conflict of interest. (©2023 JOURNAL of MEDICINE and LIFE.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|